These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 31494973)

  • 61. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians.
    Wattanakrai P; Mornchan R; Eimpunth S
    Dermatol Surg; 2010; 36(1):76-87. PubMed ID: 20298254
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Single-session intense pulsed light combined with stable fixed-dose triple combination topical therapy for the treatment of refractory melasma.
    Figueiredo Souza L; Trancoso Souza S
    Dermatol Ther; 2012; 25(5):477-80. PubMed ID: 23046029
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Objective assessment of erythema and pigmentation of melasma lesions and surrounding areas in long-term management regimens with triple combination.
    Hexsel D; Soirefmann M; Fernandes JD; Siega C
    J Drugs Dermatol; 2014 Apr; 13(4):444-8. PubMed ID: 24719064
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evaluation of the Safety and Efficacy of a Picosecond Alexandrite Laser With DLA for Acne Scars in Chinese Patients.
    Zhang M; Fang J; Wu Q; Lin T
    Lasers Surg Med; 2020 Feb; 52(2):176-181. PubMed ID: 31709575
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficacy of the 1064-nm Q-switched Nd:YAG laser in melasma.
    Suh KS; Sung JY; Roh HJ; Jeon YS; Kim YC; Kim ST
    J Dermatolog Treat; 2011 Aug; 22(4):233-8. PubMed ID: 20443754
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The efficacy and safety of topical 5% methimazole vs 4% hydroquinone in the treatment of melasma: A randomized controlled trial.
    Gheisari M; Dadkhahfar S; Olamaei E; Moghimi HR; Niknejad N; Najar Nobari N
    J Cosmet Dermatol; 2020 Jan; 19(1):167-172. PubMed ID: 31102345
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Split-face comparison of the picosecond 1064-nm Nd:YAG laser using a microlens array and the quasi-long-pulsed 1064-nm Nd:YAG laser for treatment of photoaging facial wrinkles and pores in Asians.
    Yim S; Lee YH; Choi YJ; Kim WS
    Lasers Med Sci; 2020 Jun; 35(4):949-956. PubMed ID: 31734761
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial.
    Adalatkhah H; Sadeghi-Bazargani H
    Drug Des Devel Ther; 2015; 9():4219-25. PubMed ID: 26345129
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Safety and efficacy of topical metformin 30% cream versus triple combination cream (Kligman's formula) in treating melasma: A randomized controlled study.
    AboAlsoud ES; Eldahshan RM; AbouKhodair Mohammed H; Elsaie ML
    J Cosmet Dermatol; 2022 Jun; 21(6):2508-2515. PubMed ID: 35357753
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Microneedling with Drug Delivery (Hydroquinone 4% Serum) as an Adjuvant Therapy for Recalcitrant Melasma.
    Ramírez-Oliveros JF; de Abreu L; Tamler C; Vilhena P; de Barros MH
    Skinmed; 2020; 18(1):38-40. PubMed ID: 32167455
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser.
    Alsaad SM; Ross EV; Mishra V; Miller L
    Lasers Surg Med; 2014 Dec; 46(10):736-40. PubMed ID: 25411141
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A comprehensive review of the long-term and short-term treatment of melasma with a triple combination cream.
    Torok HM
    Am J Clin Dermatol; 2006; 7(4):223-30. PubMed ID: 16901182
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Postinflammatory and rebound hyperpigmentation as a complication after treatment efficacy of telangiectatic melasma with 585 nanometers Q-switched Nd: YAG laser and 4% hydroquinone cream in skin phototypes III-V.
    Lueangarun S; Namboonlue C; Tempark T
    J Cosmet Dermatol; 2021 Jun; 20(6):1700-1708. PubMed ID: 33002283
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Combination treatment of low-fluence 1,064-nm Q-switched Nd: YAG laser with novel intense pulse light in Korean melasma patients: a prospective, randomized, controlled trial.
    Yun WJ; Moon HR; Lee MW; Choi JH; Chang SE
    Dermatol Surg; 2014 Aug; 40(8):842-50. PubMed ID: 25022705
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Successful treatment of melasma using a combination of microdermabrasion and Q-switched Nd:YAG lasers.
    Kauvar AN
    Lasers Surg Med; 2012 Feb; 44(2):117-24. PubMed ID: 22334295
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficacy of hydroquinone (2%) versus tretinoin (0.025%) as adjunct topical agents for chemical peeling in patients of melasma.
    Nanda S; Grover C; Reddy BS
    Dermatol Surg; 2004 Mar; 30(3):385-8; discussion 389. PubMed ID: 15008866
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nonablative 1550-nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled pilot study.
    Kroon MW; Wind BS; Beek JF; van der Veen JP; Nieuweboer-Krobotová L; Bos JD; Wolkerstorfer A
    J Am Acad Dermatol; 2011 Mar; 64(3):516-23. PubMed ID: 21255869
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Investigating the efficacy of a fractionated 1927 nm laser for diffuse dyspigmentation and actinic changes.
    Vingan NR; Panton JA; Barillas J; Lazzarini A; Hoopman J; Kenkel JM; Culver A
    Lasers Surg Med; 2023 Apr; 55(4):344-358. PubMed ID: 36950878
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A comparative study of low-fluence 1064-nm Q-switched Nd:YAG laser with or without chemical peeling using Jessner's solution in melasma patients.
    Lee DB; Suh HS; Choi YS
    J Dermatolog Treat; 2014 Dec; 25(6):523-8. PubMed ID: 24289244
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Fractional erbium:YAG laser (2940 nm) plus topical hydroquinone compared to intradermal tranexamic acid plus topical hydroquinone for the treatment of refractory melasma: a randomized controlled trial.
    Mokhtari F; Bahrami B; Faghihi G; Asilian A; Iraji F
    J Dermatolog Treat; 2022 Aug; 33(5):2475-2481. PubMed ID: 34387527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.